talquetamab
janssen
['multiplemyeloma', 'talquetamab', 'jnjnews', '$jnj']
overall responses of 20%-30% used to be enough for accelerated approval in #multiplemyeloma. #talquetamab topped 70% in phase 1/2 testing. is seeking fda approval; data were presented at #ash22 for the drug, which hits a novel target. $jnj #cancer
Business journalist based in #RTP, covering pharma and biotech (almost) everywhere. 71% free throw shooter. Genesis: Album 9, track 11.